Review Article

The Potential Role of Probiotics in Controlling Overweight/Obesity and Associated Metabolic Parameters in Adults: A Systematic Review and Meta-Analysis

Table 1

Characteristics of the included studies.

StudiesCountryNo. of participants (P/C)Trial NumberITTStudy designForm of probioticsProbiotics strainsDaily dose
(CFU)
Duration
(Weeks)

Szulińska 2018[31]Poland47 (24/23)NCT03100162NoDB, PCSachetMulti (Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Bifidobacterium lactis W52, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus casei W56, Lactobacillus salivarius W24, Lactococcus lactis W19, and Lactococcus lactis W58)1×101012

Kim 2018[13]Korea60 (30/30)KCT0000756YesDB, PCCapsuleSingle (Lactobacillus gasseri BNR17)1×101012

Gomes 2017[14]Brazil43 (22/21)U1111-1137-4566NoDB, PCSachetMulti (Lactobacillus acidophilus LA - 14, Lactobacillus casei LC - 11, Lactococcus lactis LL - 23, Bifidobacterium bifidum BB - 06, and Bifidobacterium lactis BL - 4)2×10108

Kim 2017[15]Korea66 (34/32)NCT02492698NoDB, PCPowderMulti (Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032)5×10912

Stenman 2016[20]Finland104 (56/48)NCT01978691ITTDB, PCSachetSingle (Bifidobacterium animalis ssp. lactis 420)1×101026

Higashikawa 2016[32]Japan41 (20/21)/ITTDB, PCPowderSingle (Pediococcus pentosaceus LP28)1×101112

Chung 2016[16]Korea37 (19/18)KCT0000452NoDB, PCCapsuleSingle (Lactobacillus JBD301)1×10912

Fathi 2016[21]Iran50 (25/25)IRCT2013061313661N1ITTDB, PCKefir//8

Madjd 2016[22]Iran89 (45/44)IRCT201402177754N8ITTSB, PCYogurtMulti (Lactobacillus acidophilus LA5, Bifidobacterium lactis BB12)1×10712

Jung 2015[17]Korea95 (46/49)/NoDB, PCPowderMulti (Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032)1×101012

Zarrati 2014[18]Iran50 (25/25)/ITTDB, PCYogurtMulti (Lactobacillus acidophilus La5, Bifidobacterium BB12, and Lactobacillus casei DN001)6×1098

Kadooka 2013[19]Japan139 (70/69)/ITTDB, PCFermented milkSingle (Lactobacillus gasseri SBT2055)2×101112

P/C, probiotic group/control group; ITT/PP, Intention-To-Treat/Per-Protocol; DB, double blinded; PC, placebo controlled; SB, single blinded; CFU, colony-forming units; 6 months.